Exome Asset Management LLC / OCUL
Exome Asset Management LLC’s Ocular Therapeutix Inc Position
Does Exome Asset Management LLC own Ocular Therapeutix Inc (OCUL)? Not currently — the last reported position was 193.6K shares worth $2M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$2M
Q1 2024
Shares
193.6K
% of Portfolio
+1.51%
Quarters Held
1
position exited
Position History OCUL
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2024 | 193.6K | $2M | +1.51% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Exome Asset Management LLC’s full portfolio or all institutional holders of OCUL.